P02-233 - Clinical audit on nice guidance on anticholinesterases in a memory clinic

Abstract

IntroductionThe National Institute for Clinical Excellence (NICE) has laid down certain guidelines for prescribing Anti-cholinesterases in patients with dementia. Keeping in mind the NICE guidance, an audit was conducted to see whether these were followed.Aims and objectivesTo ascertain the level of compliance to the NICE guidance and ensure they are adhered to.MethodThe data was collected from patients attending the memory clinic at Park Royal Centre for Mental Health in Central London over a six month period. Sixteen patients were randomly selected for this audit. The baseline MMSE score was recorded and also the medication prescribed.ResultsThe baseline MMSE score in all the 16 (100%) patients was above the recommended score of 12.The MMSE score was done in 12(75%) patients during follow up at 4–6 months.Of the 12 available MMSE scores at follow up, none were below 12 and hence continued treatment.In 2 (12.5%) patients there was an improvement, in 6 (37.5%) patients there was a fall and in 4 (25%) patients there was no change in the MMSE score at follow up.ConclusionIt was found that the NICE guidance was followed in most (75%) patients.